General. All chemicals were used as received from the manufacturer (Aldrich Chemicals and Fisher Scientific) and all reactions were carried out under a nitrogen or argon atmosphere. All solvents were dried over 4 Å molecular sieves prior to their use. NMR spectra were obtained on either a Bruker 300 MHz spectrometer or a Bruker 500 MHz spectrometer in CDCl 3 , d 6 --DMSO or d 6 --acetone solutions. IR spectra were recorded on a Nicolet Avatar 320 FT--IR spectrometer with an HATR attachment. High--resolution mass spectra were provided on a Biotof Q electrospray mass spectrometer at the University of Richmond or an AxION 2 time of flight mass spectrometer at Virginia Commonwealth University. Low--resolution MS spectra were obtained on a Shimadzu QP 5050 instrument. Melting points and boiling points are uncorrected. Flash chromatographic separations were carried out on a Biotage SP--1 instrument, which was equipped with a silica cartridge, and ethyl acetate/hexane used as the eluant. Microwave accelerated reactions were carried out in a Biotage Initiator system. Microwave reactions were controlled at a constant temperature whereby the microwave power was allowed to fluctuate so as to maintain a constant temperature and safe pressure limits. TLC analyses were conducted on silica plates with hexane/ethyl acetate as the eluant. Vinamidinium salts utilized for pyrrole formation were prepared according to standard procedures. S1 All purified reaction products gave TLC results, MS spectra, flash chromatograms and 13 C NMR spectra consistent with a sample purity of >95%. Scheme 1 depicts Method A and Method B, which were used for the preparation of the pyrrole analogs with one exception. Compound 5q was prepared by bromination of compound 2 with dibromdimethylhydantioin as indicated in the experimental procedures that follow.
Scheme S1. Preparation of Pyrrole Analogs. Table 1 were purified by preparative chromatography. A typical chromatogram, as illustrated for compound 4g is shown in Figure  S1 and subsequent HPLC analysis of the purified material is presented in Figure S2 . Figure S1 . This material (4g) was purified on a Biotage SP--1 preparative chromatograph using a silica column with a hexane/ethyl acetate gradient. The fraction represented in yellow was collected and characterized as compound 4g. Figure  S2 . This chromatogram represents the HPLC analysis of purified compound 4g on an Inertsil ODS--II column in an isocratic mode with a 1:1 mixture of methanol:acetonitrile. Figure S3 . This material (5g) was purified on a Biotage SP--1 preparative chromatograph using a silica column with a hexane/ethyl acetate gradient. The fraction represented in blue was collected and characterized as compound 5g. Figure  S4 . This chromatogram represents the HPLC analysis of purified compound 5g on an Inertsil ODS--II column in an isocratic mode with a 1:1 mixture of methanol:acetonitrile.
Assessment of purity. All new compounds (including their precursors) listed in

Synthesis of 4--phenyl--1H--pyrrole--2--carboxylic acid ethyl ester 4a.
The preparation of this material has been previously reported.
S1
Synthesis of 4--(4--methylphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 4b.
S1
Synthesis of 4--(4--chlorophenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 4c.
The preparation of this material has been previously reported. S1 
Synthesis of 4--(4--bromophenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 4d.
Synthesis of 4--(4--methoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 4e.
Synthesis of 4--(3--methoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 4f. Method A.
Into a 100 mL, three--necked round bottom flask was placed sodium hydride [0.127 g (60% by weight), 5.28 mmol], t--butanol (0.75 mL, 7.9 mmol) and 30 mL of dry DMF. The sodium hydride was allowed to react until there was no evolution of hydrogen gas. The reaction mixture was then cooled in an ice bath and glycine ethyl ester hydrochloride (0.368g, 2.64 mmol) was added, and the resulting mixture was stirred for 30 mins at room temperature. Subsequently, 3--methoxyphenylvinamidinium hexafluorophosphate S1 (0.500 g, 1.32 mmol) was added to the reaction flask and the resulting contents were refluxed for 24 hrs. After cooling to room temperature, the reaction mixture was diluted with 100 mL of water and extracted with ethyl acetate (2 x 50 mL). The combined organic extracts were washed with water (2 x 50 mL), brine (2 x 50 mL) and dried over anhydrous sodium sulfate. 7, 160.1, 136.2, 129.8, 126.5, 123.6, 120.3, 117.9, 112.7, 111.6, 111.0, 60.7, 55.2 and 29.8; IR (neat) 7, 134.0, 133.4, 131.9, 128.4, 127.2, 126.9, 126.1, 125.9, 125.8, 125.6, 125.2, 123.2, 122.6, 116.4, 60.6 7.12 (t, J = 8.0 Hz, 1H), 4.32 (q, J = 7.0 Hz, 2H) and 1.36 (t, J = 7.0 Hz, 3H) ; 13 C NMR (CDCl 3 ) δ 160.7, 137.1, 126.0, 123.0, 121.4, 121.3, 120.4, 119.7, 119.4, 119.3, 112.8, 111.5, 110.9, 59.5 and 13.9; IR (neat) 
Synthesis of 4--(4--trifluoromethoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 4j. Method B.
Into a 20 mL microwave vial equipped with a stirring bar was placed 4--bromo--1H--pyrrole--2--carboxylic acid ethyl ester (6) S3 6, 147.6, 133.6, 126.4, 125.4, 123.9, 121.3, 120.6 (q, J = 256. 300.0842, found 300.0827. 
Synthesis of 4--(4--thiomethylphenyl)--1H--pyrrole--2--
Synthesis of 4--(3,4--dichlorophenyl)--1H--pyrrole--2--carboxylic acid ethyl ester
Synthesis of 4--(3--fluoro--4--methoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester
Synthesis of 4--(6--ethoxynaphthalen--2--yl)--1H--pyrrole--2--carboxylic acid ethyl ester 4n.
This compound was prepared according to Method B with the exception that (6--ethoxynaphthalen--2--yl)boronic was used instead of 4--trifluoromethoxyphenylboronic acid for the cross--coupling reaction in which case an 14% yield of a yellow solid was obtained. 133.4, 129.7, 129.3, 129.2, 127.2, 127.1, 124.8, 123.9, 123.1, 119.4, 119.3, 112.4, 106.6, 63.5, 60.5, 14.8 and 14.5 
Synthesis of 3,5--dibromo--4--(3,4--dimethoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 2.
S4
Synthesis of 3,5--dibromo--4--phenyl--1H--pyrrole--2--carboxylic acid ethyl ester 5a.
The preparation of this material has been previously reported. 
S4
Synthesis of 3,5--dibromo--4--(4--methylphenyl)--1H--pyrrole--2--
Synthesis of 3,5--dibromo--4--(4--chlorophenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5c.
S4
Synthesis of 3,5--dibromo--4--(4--bromophenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5d.
S4
Synthesis of 3,5--dibromo--4--(4--methoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5e.
S4
Synthesis of 3,5--dibromo--4--(3--methoxyphenyl)--1H--pyrrole--2--
Synthesis of 3,5--dibromo--4--(3,4,5--trimethoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5g.
Into a 100 mL round bottom flask equipped with a magnetic stir bar, was placed 4--(3,4,5--trimethoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 4g (0.250 g, 0.819 mmol) and potassium hydroxide (0.184 g, 3.27 mmol) in 20 mL of dry DMF. The reaction mixture was stirred for 15 mins at room temperature after which pyridinium tribromide (0.524 g, 1.64 mmol) was added and the reaction mixture was allowed to stir overnight at room temperature. The reaction mixture was subsequently diluted with 30 mL of water, extracted with ethyl acetate (3 x 25 mL), washed with brine (1 x 15 mL) and dried over anhydrous sodium sulfate. After filtering off the drying agent the organic phase was concentrated in vacuo to give a light yellow solid. The crude product was purified using a Biotage Flash Purification SP--1 system to give a light yellow solid (0.274 g, 73% yield 
Synthesis of 3,5--dibromo--4--(1--naphthyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5h.
This compound was prepared in a manner identical to compound 5g with the exception that compound 4h was used as the starting material. Subsequently, a 62% yield of a tan solid was obtained and this material exhibited the following physical properties: mp 144 -146 °C; 1 H NMR (CDCl 3 ) δ 7.94 (m, 2H), 7.67 (d, J = 7.8 Hz, 1H), 7.51 (m, 4H), 4.48 (q, J = 6.9 Hz, 2H) and 1.46 (t, J = 6.9 Hz, 3H); 13 C NMR (CDCl 3 ) δ 160.3, 133.7, 132.2, 129.9, 129.3, 129.0, 128.4, 126.3, 126.1, 126.0, 125.9, 125.3, 122.0, 106.3, 106.0, 61.5 and 14.4; IR (neat) 
Synthesis of 3,5--dibromo--4--(3--indolyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5i.
This compound was prepared in a manner identical to compound 5g with the exception that compound 4i was used as the starting material. Subsequently, a 68% yield of a dark solid was obtained and this material exhibited the following physical properties: mp 118 -121 °C; 1 H NMR (CDCl 3 ) δ 7.42 (d, J = 7.5 Hz, 2H), 7.18 (t, J = 7.5 Hz, 1H), 7.09 (t, J = 7.5 Hz, 1H), 6.99 (s, 1H), 4.31 (q, J = 7.2 Hz, 2H) and 1.34 (t, J = 7.2 Hz, 3H); 13 C NMR (CDCl 3 ) δ 158. 6, 137.1, 126.9, 123.3, 122.1, 120.6, 118.7, 115.2, 113.8, 111.9, 108.1, 106.7, 105.7, 60.4 and 13.8; IR (neat) 
Synthesis of 3,5--dibromo--4--(4--trifluoromethoxyphenyl)--1H--pyrrole--2--
Synthesis of 3,5--dibromo--4--(4--thiomethylphenyl)--1H--pyrrole--2--
Synthesis of 3,5--dibromo--4--(3,4--dichlorophenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5l.This
compound was prepared in a manner identical to compound 5g with the exception that compound 4l was used as the starting material. Subsequently, a 56% yield of a tan solid was obtained and this material exhibited the following physical properties: mp 180 -183 °C; 
Synthesis of 3,5--dibromo--4--(3--fluoro--4--methoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester
5m. This compound was prepared in a manner identical to compound 5g with the exception that compound 4m was used as the starting material. Subsequently, a 55% yield of a tan solid was obtained and this material exhibited the following physical properties: mp 169 -171 °C; 1 H NMR (CDCl 3 ) δ 7.14--7.21 (m, 2H), 7.05 (t, J = 8.7 Hz, 1H), 4.41 (q, J = 7.2 Hz, 2H) and 1.43 (t, J = 7.2 Hz, 3H); ,5--dibromo--4--(6--ethoxynaphthalen--2--yl)--1H--pyrrole--2-- 4.19 (q, J = 6.9 Hz, 2H), 1.52 (t, J = 6.9 Hz, 3H) and 1.45 (t, J = 7.2 Hz, 3H) ; 13 C NMR (CDCl 3 ) δ 159. 5, 157.4, 134.0, 129.6, 129.3, 128.6, 128.3, 127.1, 126.9, 126.5, 121.8, 119.4, 106.5, 104.4, 104.3, 63.6, 61.3, 14.8 and 14.4; IR (neat) ,5--dibromo--4--benzo[1,3]dioxol--5--yl--1H--pyrrole--2-- 7, 147.4, 147.3, 126.7, 125.4, 124.1, 121.7, 110.7, 108.2, 104.5, 104.2, 101.2, 61.3 and 14.4; IR (neat) ,5--dibromo--4--(2,3--dihydro--benzo[1,4] 143.4, 143.2, 126.3, 125.1, 123.5, 121.7, 119.1, 117.1, 104.8, 104.2, 64.4, 64.3, 61.4 and 14.4; IR (neat) 
Synthesis of 3
Synthesis of 3,5--dibromo--4--(2--bromo--3,4--dimethoxyphenyl)--1H--pyrrole--2--carboxylic acid ethyl ester 5q.
Into a 100 mL round bottom flask equipped with a magnetic stir bar, was placed compound 2 (0.125 g, 0.290 mmol), dibromodimethylhydantoin (0.083 g, 0.290 mmol) and 15 mL of chloroform. The resulting reaction mixture was refluxed for 4 hours and cooled to room temperature. The reaction mixture was then diluted with 20 mL of chloroform and washed with sodium thiosulfate solution (2 x 30 mL), brine (2 x 30mL), dried with anhydrous sodium sulfate, filtered and concentrated in vacuo to give a light yellow solid (0.12 g, 76% yield), which exhibited the following physical properties: mp 165 -167 °C; 1 H NMR (CDCl 3 ) δ 6.97 (m, 2H), 4.42 (q, J = 7.2 Hz, 2H), 3.89 (s, 6H) and 1.39 (t, J = 7.2 Hz, 3H); 13 C NMR (CDCl 3 ) δ 160.3, 148.6, 148.4, 126.5, 124.5, 122.8, 121.7, 113.5, 110.8, 105.1, 104.1, 61.5, 55.9, 55.8 and 14.4 
Biological Activity
Cell Culture. The MDA--MB--435 human melanoma cancer cell line was obtained from the Lombardi Cancer Center (Georgetown University; Washington, DC) and grown in Richter's IMEM medium (Invitrogen; Carlsbad, CA) supplemented with 10% fetal bovine serum (Hyclone; Logan, UT) and 25 μg/mL gentamicin sulfate (Invitrogen). The A--10 embryonic rat aortic smooth muscle cell line was purchased from American Type Culture Collection (Manassas, VA) and cultured in Basal Medium Eagle medium (Sigma; St. Louis, MO) with 10% fetal bovine serum and 50 µg/mL gentamicin sulfate.
Inhibition of Cellular Proliferation. Antiproliferative effects were evaluated using the SRB assay S5 as previously described. S6 The concentration of drug that caused a 50% inhibition of cellular proliferation (IC 50 ) was calculated from the linear portion of the log of the dose response curve. Each IC 50 represents the mean and standard deviation from three independent experiments, each performed in triplicate. Colchicine is included as a reference compound.
Immunofluorescence. Cellular microtubules in interphase were visualized using indirect immunofluorescence techniques as previously described. S6 Cells were treated for 18 h with vehicle or drug, fixed with methanol and microtubules visualized with a β--tubulin antibody using a Nikon Eclipse 80i fluorescence microscope. Percent microtubule depolymerization as compared to vehicle treated controls was determined visually.
Molecular Modeling
Sybyl 8.1 S7 was used to prepare the X--ray crystal structure models of αβ--tubulin complexed with different ligands (pdbid: 1sa0, 1sa1, 3hkc, 3hkd and 3hke). S8,S9 For each structure, the procedure was the same as previously reported. S10 The stathmin--like domain, the C and D subunits, were deleted. Hydrogen atoms were added and their orientations were optimized by the Tripos force field to a gradient of 0.005 kcal mol --1 Å --1 . GOLD 5.1 S11 was used for docking studies. The ligands were docked in the active site, which was defined by the space in a 6 Å radius around the complexed small molecule. One hundred GA runs generated one hundred docking conformations for each ligand with GOLD and were filtered initially by GoldScore. They were further analyzed with HINT. S12 First, the ligands were docked to all five tubulin structures with GOLD without constraints. The resulting conformations were rescored with HINT and the best docking poses were indicated by the highest HINT score. Next, the differences between ligand binding to the five receptors for each ligand were checked and it was found that binding with 3hkc generally gave higher scores. The resulting 3hkc--ligand complexes were further minimized with the Tripos force field and rescored again. The minimized conformation and the new HINT score were defined as the docking conformation/binding mode and binding score of the ligand.
It is important to note that although it binds in a similar fashion, the complexed ligand in 3hkc, N--{2--[(4--hydroxylphenyl)amino]pyridin--3--yl}--4--methoxybenzenesulfonamide ( Figure S5 ) is structurally different from the pyrrole--based compounds reported here or colchicine. 
